Dr. Reddy's Laboratories
RDY
#1699
Rank
$11.86 B
Marketcap
$14.19
Share price
0.35%
Change (1 day)
-1.32%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): $0.91 Billion USD

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are $3.95 Billion USD. In 2024 the company made an earning of $0.89 Billion USD, an increase over its 2023 earnings that were of $0.83 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.91 B2.35%
2024 $0.89 B7.01%
2023 $0.83 B17.62%
2022 $0.71 B43.27%
2021 $0.49 B31.44%
2020 $0.37 B54.54%
2019 $0.24 B-14.21%
2018 $0.28 B26.15%
2017 $0.22 B4.69%
2016 $0.21 B-55.7%
2015 $0.48 B1.83%
2014 $0.47 B-3.78%
2013 $0.49 B54.07%
2012 $0.32 B-16.23%
2011 $0.38 B56.66%
2010 $0.24 B-235.36%
2009 -$0.19 Billion-198.53%
2008 $0.18 B30.77%
2007 $0.14 B-14.61%
2006 $0.16 B703.63%
2005 $20.59 M649.45%
2004 $2.74 M-95.68%
2003 $63.55 M-14.86%
2002 $74.64 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$11.85 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.77 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$9.32 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
$16.41 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$9.10 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France